Biologically active components of cobra venom in relation to cancer research.
D000818:Animals; D000970:Antineoplastic Agents / Q000302:isolation & purification*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D002478:Cells, Cultured; D005354:Fibrosarcoma / Q000188:drug therapy; D051379:Mice; D011506:Proteins / Q000302:isolation & purification*; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy; D012517:Sarcoma, Yoshida / Q000188:drug therapy; D012910:Snake Venoms / Q000032:analysis*
D000970:Antineoplastic Agents; D011506:Proteins; D012910:Snake Venoms